Cited by 26Hormonal and reproductive studiesAdrenal Hormones and DisordersHypothalamic control of reproductive hormones

The DOI matches its Crossref record; its reference list is not available.

Characteristics of Men Undergoing Testosterone Replacement Therapy and Adherence to Follow-up Recommendations in Metropolitan Multicenter Health Care System

Abstract

Objective To identify the frequencies of treatment and recommended laboratory follow-up for men with low serum testosterone levels. Methods The Electronic Data Warehouse was queried to identify men of ages 18-85 years, who obtained a testing for serum total testosterone level from 2009 to 2012. The frequency of testosterone replacement therapy (TRT), patient demographics, and clinical characteristics were collected. The frequency of follow-up with serum total testosterone and complete blood count levels was documented. Results Among 9176 men who underwent testing for low testosterone levels, 3320 (36%) of them were hypogonadal with a mean serum total testosterone level of 194.3 ± 64.9 ng/dL. Of them, 17.7% men were treated with TRTs. The treatment frequency significantly increased from 8.3% in 2009 to 24% in 2012. A total of 4.8% of men of reproductive ages (age, 18-35 years) were placed on TRTs. Within 180 days of initial testing, only 40% of treated men received follow-up with liver function tests and/or complete blood count, and only 49% had a follow-up serum testosterone level. Conclusion Although the frequency of TRT is increasing, only a small percentage of hypogonadal men are actively undergoing treatment. A significant proportion of men of reproductive age are being treated with significant impacts on potential fertility. Less than half of the patients treated are being monitored appropriately after testosterone replacement. This highlights the importance of further e…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.urology.2015.01.027

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 27 · Cited by 26

Research works printed but not linked: 20

  1. Dandona, 2010, A practical guide to male hypogonadism in the primary care setting, Int J Clin Pract, 64, 682, 10.1111/j.1742-1241.2010.02355.x · DOI
  2. Margo, 2006, Testosterone treatments: why, when, and how?, Am Fam Physician, 73, 1591
  3. Bhasin, 2006, Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, 91, 1995, 10.1210/jc.2005-2847 · DOI · Paper page
  4. Traish, 2009, The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction, J Androl, 30, 10
  5. Jones, 2003, Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: further supportive data, J Clin Endocrinol Metab, 88, 1403, 10.1210/jc.2002-021738 · DOI
  6. Meier, 2008, Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study, Arch Intern Med, 168, 47, 10.1001/archinternmed.2007.2 · DOI · Paper page
  7. Mohr, 2007, Testosterone, sex hormone-binding globulin, and frailty in older men, J Am Geriatr Soc, 55, 548, 10.1111/j.1532-5415.2007.01121.x · DOI
  8. Bates, 2005, Androgens, andropause and neurodegeneration: exploring the link between steroidogenesis, androgens and Alzheimer’s disease, Cell Mol Life Sci, 62, 281, 10.1007/s00018-004-4383-1 · DOI
  9. Gooren, 2007, Diagnosing and treating testosterone deficiency in different parts of the world. Results from global market research, Aging Male, 10, 173, 10.1080/13685530701600885 · DOI
  10. Wang, 2009, ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males, Aging Male, 12, 5, 10.1080/13685530802389628 · DOI
  11. Petak, 2002, American Association of Clinical Endocrinologists Medical Guidelines for the clinical practice for evaluation and treatment of hypogonadism in adult male patients—2002 update, Endocr Pract, 8, 439, 10.4158/EP.8.6.439 · DOI
  12. Wang, 2001, Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men, Clin Endocrinol (Oxf), 54, 739, 10.1046/j.1365-2265.2001.01271.x · DOI
  13. Layton, 2014, Testosterone lab testing and initiation in the United Kingdom and the United States, 2000-2011, J Clin Endocrinol Metab, 99, 835, 10.1210/jc.2013-3570 · DOI
  14. Wittert, 2003, Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status, J Gerontol A Biol Sci Med Sci, 58, 618, 10.1093/gerona/58.7.M618 · DOI
  15. Mårin, 1992, Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues, Eur J Med, 1, 329
  16. Carruthers, 2009, Time for international action on treating testosterone deficiency syndrome, Aging Male, 12, 21, 10.1080/13685530802699067 · DOI
  17. Cabana, 1999, Why don't physicians follow clinical practice guidelines? A framework for improvement, JAMA, 282, 1458, 10.1001/jama.282.15.1458 · DOI · Paper page
  18. Kahn, 2013, Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism, Cochrane Database Syst Rev, 7, CD008201
  19. Carruthers, 2007, The validity of androgen assays, Aging Male Off J Int Soc Study Aging Male, 10, 165, 10.1080/13685530701483738 · DOI
  20. Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321 · DOI · Paper page

Metadata

Authors
Malik, R. D., Wang, C. E., Lapin, B., Lakeman, J. C., & Helfand, B. T.
Affiliations
  • University of Chicago Medical Center (US)
  • Endeavor Health (US)
Corresponding author
Malik, Rena D.
Venue
Urology
Publisher
Elsevier BV
Published
2015-06
Volume
85
Issue
6
Pages
1382-1388
ISSN
0090-4295 (ISSN-L)
OpenAlex
W2042842990
Cited by
26
References
27
Citations by year
2026: 3 · 2025: 2 · 2024: 2 · 2023: 4 · 2022: 7 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 2 · 2016: 1
FWCI
0.87
Type
journal article
Language
en
Open access
closed
Locations
  • Urology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
testosterone replacement therapy, hypogonadism, follow-up monitoring, medication adherence, liver function tests, complete blood count, men of reproductive age, fertility, prescribing education
MeSH terms
Adolescent, Adult, Aged, Androgens, Follow-Up Studies, Health Facilities, Humans, Male, Middle Aged, Testosterone, Guideline Adherence, Hormone Replacement Therapy, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characteristics of Men Undergoing Testosterone Replacement Therapy and Adherence to Follow-up Recommendations in Metropolitan Multicenter Health Care System. https://app.cochat.ai/papers/10.1016/j.urology.2015.01.027
The paper
Malik, R. D., Wang, C. E., Lapin, B., Lakeman, J. C., & Helfand, B. T. (2015). Characteristics of Men Undergoing Testosterone Replacement Therapy and Adherence to Follow-up Recommendations in Metropolitan Multicenter Health Care System. Urology. https://doi.org/10.1016/j.urology.2015.01.027